Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen. A multinational ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new ...

This cartoon shows the newly identified mefloquine binding site causing the changes in the ribosome's dynamics which promote read-through of the premature stop codons. The main interactions are shown ...

Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Researchers led by teams at the University of California, Riverside (UCR), the University of California, Irvine, and the Yale School of Medicine have developed a compound that they found to be ...

A team of metabolic specialists and molecular biologists at Fudan University's Zhongshan Hospital, working with colleagues from other institutions in China, has found that some antimalarial drugs show ...

Most people with lupus take an antimalarial drug to control their symptoms. These drugs may also prevent blood clots and damage to your organs from lupus. Antimalarials are mostly safe to use and ...

Tabitha Mwangi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...